Table 4 Classification and definition of pharmaceutical care issues
Pharmaceutical care issue | Definition |
|---|---|
Monitoring | An intermittent (regular or irregular) series of observations in time, carried out to determine the effectiveness, safety and adherence of the drug therapy. |
Drug-drug interaction | A combination of two or more drugs, administered by one patient that can result in a modification of the effect of at least one drug. The effect may be an undesired effect or a lack of effect of the drug. |
Contra-indicated drug | A drug that is undesired because of the medical condition of the patient, which can lead to an adverse drug event or a lack of effect of the drug or a worsening of the medical condition of the patient. |
Lifestyle | The lifestyle of the patient that could interfere with effective and safe drug therapy or that could result in non-adherence. |
Double medication | Therapeutic duplication is defined as the use of two or more drugs in the same ATC classification and with similar pharmacodynamic properties, which can lead to adverse drug events. |